MDD

TITUSVILLE, NEW JERSEY, May 04, 2026 Johnson & Johnson has announced new findings demonstrating that CAPLYTA® (lumateperone) achieved the...

BURLINGTON, Mass. and JERUSALEM, March 31, 2026 BrainsWay Ltd. announced that the U.S. Food and Drug Administration (FDA) has...

Chatham, New Jersey, November 24, 2025 — Tonix Pharmaceuticals announced that the U.S. Food & Drug Administration has cleared...